RecruitingNot Applicable

Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer

China858 participantsStarted 2024-09-13

Plain-language summary

The purpose of this study is to compare the live birth rates of high concentration of Hyaluronic Acid (0.5 mg/ml) transfer medium (EmbryoGlue®) to those containing low Hyaluronic Acid concentrations (0.125 mg/ml) (G2 medium) in women undergoing single fresh and frozen blastocyst transfer.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. All cycles with single blastocyst transfer will be considered eligible
. Both fresh and cryopreserved embryo transfer cycles utilizing autologous oocytes
. No age restriction will be applied
. Informed consent was signed

Exclusion criteria

. Uterine anatomic anomalies
. Women with untreated hydrosalpines
. Once couples have been enrolled in the trial, subsequent cycles will not be incorporated.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Live birth rate

Timeframe: Live birth is defined as the birth of at least one live baby after 24 weeks of gestation.

Trial details

NCT IDNCT06492785

SponsorNorthwest Women's and Children's Hospital, Xi'an, Shaanxi

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

Contact for this trial

He Cai, Doctor

13581613908 caihe@bjmu.edu.cn

View on ClinicalTrials.gov More Infertility trials

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. All cycles with single blastocyst transfer will be considered eligible
. Both fresh and cryopreserved embryo transfer cycles utilizing autologous oocytes
. No age restriction will be applied
. Informed consent was signed

Exclusion criteria

. Uterine anatomic anomalies
. Women with untreated hydrosalpines
. Once couples have been enrolled in the trial, subsequent cycles will not be incorporated.